FULGENT GENETICS, INC. Depreciation
FULGENT GENETICS, INC. (FLGT) reported Depreciation of $5.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-30
- FULGENT GENETICS, INC. depreciation for the quarter ending 2026-06-30 was $5.00M, a 28.21% increase year-over-year.
- FULGENT GENETICS, INC. depreciation for the quarter ending 2026-03-31 was $3.90M, a 2.63% increase year-over-year.
- FULGENT GENETICS, INC. depreciation for the quarter ending 2025-12-31 was $4.00M, a 0.00% change year-over-year.
- FULGENT GENETICS, INC. depreciation for the quarter ending 2025-09-30 was $3.90M, a 2.63% increase year-over-year.
- FULGENT GENETICS, INC. depreciation for fiscal 2025 was $15.70M, a 4.27% decline from fiscal 2024.
- FULGENT GENETICS, INC. depreciation for fiscal 2024 was $16.40M, a 6.29% decline from fiscal 2023.
- FULGENT GENETICS, INC. depreciation for fiscal 2023 was $17.50M, a 31.37% decline from fiscal 2022.
- FULGENT GENETICS, INC. depreciation for fiscal 2022 was $25.50M, a 174.19% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-07-30 | $8.90M 10-Q · filed 2026-07-30 | $12.90M derived: sum of 3 quarters · filed 2026-07-30 | $16.80M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $3.90M 10-Q · filed 2026-05-01 | $7.90M derived: sum of 2 quarters · filed 2026-05-01 | $11.80M derived: sum of 3 quarters · filed 2026-05-01 | $15.70M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.90M derived: sum of 2 quarters · filed 2026-02-27 | $11.80M derived: sum of 3 quarters · filed 2026-07-30 | $15.70M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $3.90M 10-Q · filed 2025-11-07 | $7.80M derived: sum of 2 quarters · filed 2026-07-30 | $11.70M 10-Q · filed 2025-11-07 | $15.60M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $3.90M 10-Q · filed 2026-07-30 | $7.70M 10-Q · filed 2026-07-30 | $11.70M derived: sum of 3 quarters · filed 2026-07-30 | $15.50M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $3.80M 10-Q · filed 2026-05-01 | $7.80M derived: sum of 2 quarters · filed 2026-05-01 | $11.60M derived: sum of 3 quarters · filed 2026-05-01 | $15.60M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.80M derived: sum of 2 quarters · filed 2026-02-27 | $11.80M derived: sum of 3 quarters · filed 2026-02-27 | $16.40M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $3.80M 10-Q · filed 2025-11-07 | $7.80M derived: sum of 2 quarters · filed 2025-11-07 | $12.40M 10-Q · filed 2025-11-07 | $16.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $4.00M 10-Q · filed 2025-08-01 | $8.60M 10-Q · filed 2025-08-01 | $13.00M derived: sum of 3 quarters · filed 2026-02-27 | $17.30M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $4.60M 10-Q · filed 2025-05-02 | $9.00M derived: sum of 2 quarters · filed 2026-02-27 | $13.30M derived: sum of 3 quarters · filed 2026-02-27 | $17.40M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.70M derived: sum of 2 quarters · filed 2026-02-27 | $12.80M derived: sum of 3 quarters · filed 2026-02-27 | $17.50M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $4.30M 10-Q · filed 2024-11-08 | $8.40M derived: sum of 2 quarters · filed 2024-11-08 | $13.10M 10-Q · filed 2024-11-08 | $20.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $4.10M 10-Q · filed 2024-08-02 | $8.80M 10-Q · filed 2024-08-02 | $16.40M derived: sum of 3 quarters · filed 2025-02-28 | $24.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $4.70M 10-Q · filed 2024-05-03 | $12.30M derived: sum of 2 quarters · filed 2025-02-28 | $19.90M derived: sum of 3 quarters · filed 2025-02-28 | $26.50M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $15.20M derived: sum of 2 quarters · filed 2025-02-28 | $21.80M derived: sum of 3 quarters · filed 2025-02-28 | $25.50M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $7.60M 10-Q · filed 2023-11-03 | $14.20M derived: sum of 2 quarters · filed 2023-11-03 | $17.90M 10-Q · filed 2023-11-03 | $20.50M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $6.60M 10-Q · filed 2023-08-04 | $10.30M 10-Q · filed 2023-08-04 | $12.90M derived: sum of 3 quarters · filed 2024-02-28 | $15.40M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $3.70M 10-Q · filed 2023-05-05 | $6.30M derived: sum of 2 quarters · filed 2024-02-28 | $8.80M derived: sum of 3 quarters · filed 2024-02-28 | $11.10M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.10M derived: sum of 2 quarters · filed 2024-02-28 | $7.40M derived: sum of 3 quarters · filed 2024-02-28 | $9.30M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $2.50M 10-Q · filed 2022-11-07 | $4.80M derived: sum of 2 quarters · filed 2022-11-07 | $6.70M 10-Q · filed 2022-11-07 | $7.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $2.30M 10-Q · filed 2022-08-04 | $4.20M 10-Q · filed 2022-08-04 | $5.40M derived: sum of 3 quarters · filed 2023-02-28 | $6.12M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $1.90M 10-Q · filed 2022-05-05 | $1.92M 10-Q · filed 2021-05-07 | $3.10M derived: sum of 2 quarters · filed 2023-02-28 | $3.82M derived: sum of 3 quarters · filed 2023-02-28 | $4.37M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.92M derived: sum of 2 quarters · filed 2023-02-28 | $2.47M derived: sum of 3 quarters · filed 2023-02-28 | $3.00M 10-K · filed 2023-02-28 | $2.96M 10-K · filed 2021-03-08 | |||
| 2020-09-30 | $722.00K 10-Q · filed 2021-11-09 | $1.27M derived: sum of 2 quarters · filed 2021-11-09 | $1.80M 10-Q · filed 2021-11-09 | $1.84M 10-Q · filed 2020-11-09 | $2.39M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $549.00K 10-Q · filed 2021-08-10 | $1.10M 10-Q · filed 2021-08-10 | $1.12M 10-Q · filed 2020-08-05 | $1.67M derived: sum of 3 quarters · filed 2022-02-28 | $2.17M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $569.00K 10-Q · filed 2021-05-07 | $1.12M derived: sum of 2 quarters · filed 2022-02-28 | $1.62M derived: sum of 3 quarters · filed 2022-02-28 | $2.13M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.05M derived: sum of 2 quarters · filed 2022-02-28 | $1.56M derived: sum of 3 quarters · filed 2022-02-28 | $2.10M 10-K · filed 2022-02-28 | $2.11M 10-K · filed 2020-03-13 | |||
| 2019-09-30 | $503.00K 10-Q · filed 2020-11-09 | $1.01M derived: sum of 2 quarters · filed 2020-11-09 | $1.55M 10-Q · filed 2020-11-09 | $2.09M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $511.00K 10-Q · filed 2020-08-05 | $1.05M 10-Q · filed 2020-08-05 | $1.58M derived: sum of 3 quarters · filed 2020-08-05 | $2.13M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $535.00K 10-Q · filed 2020-05-06 | $1.07M derived: sum of 2 quarters · filed 2020-05-06 | $1.62M derived: sum of 3 quarters · filed 2020-05-06 | $2.18M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.08M derived: sum of 2 quarters · filed 2020-03-13 | $1.65M derived: sum of 3 quarters · filed 2020-03-13 | $2.16M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $547.00K 10-Q · filed 2019-11-08 | $1.11M derived: sum of 2 quarters · filed 2019-11-08 | $1.63M 10-Q · filed 2019-11-08 | $2.10M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $562.00K 10-Q · filed 2019-08-12 | $1.08M 10-Q · filed 2019-08-12 | $1.55M derived: sum of 3 quarters · filed 2019-08-12 | $1.99M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $516.00K 10-Q · filed 2019-05-10 | $989.00K derived: sum of 2 quarters · filed 2019-05-10 | $1.43M derived: sum of 3 quarters · filed 2019-05-10 | $1.83M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $911.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.32M derived: sum of 3 quarters · filed 2019-03-22 | $1.73M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $438.00K 10-Q · filed 2018-11-09 | $843.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.25M 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | $405.00K 10-Q · filed 2018-08-13 | $817.00K 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |